(Q34787956)

4 August 2017

1 reference

title

Review of antifungal therapy, part II: treatment rationale, including specific patient populations (English)

1 reference

4 August 2017

1 reference

Robert Baran

1

1 reference

4 August 2017

Rod J Hay

series ordinal

2

1 reference

4 August 2017

Javier I Garduno

series ordinal

3

1 reference

4 August 2017

publication date

1 January 2008

1 reference

Journal of Dermatological Treatment

4 August 2017

published in

1 reference

4 August 2017

volume

19

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

168-175

1 reference

Onychomycosis in children: a brief overview with treatment strategies

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Epidemiology and prevalence of onychomycosis in HIV-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Clinical patterns of Fusarium infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Spectrum of dermatological lesions in renal allograft recipients in a tropical environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Current management of onychomycosis. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Prediction of outcome in the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Combination therapy for onychomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Testing of antifungal combinations against yeasts and dermatophytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Terbinafine in onychomycosis of the toenail: A novel treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Superficial white onychomycosis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Open randomized comparison of itraconazole versus terbinafine in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Nail fungal infections and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Onychomycosis: strategies to improve efficacy and reduce recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

The immune response to dermatophytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Chronic dermatophytosis caused by Trichophyton rubrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Experimental study of resistance to infection by Trichophyton mentagrophytes: demonstration of memory skin cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Trichophyton mentagrophytes spores differ from mycelia in their ability to induce pustules and activate complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Evaluation of lymphocytes subpopulations and natural killer cells in peripheral blood of patients treated for dermatophyte onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

Onychomycosis in children: prevalence and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701657187

10.1080/09546630701657187

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference